Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Raw Materials (2016 - 2018)

Apyx Medical's Raw Materials history spans 3 years, with the latest figure at $4.5 million for Q4 2018.

  • For Q4 2018, Raw Materials fell 12.43% year-over-year to $4.5 million; the TTM value through Dec 2018 reached $4.5 million, down 12.43%, while the annual FY2018 figure was $4.5 million, 12.43% down from the prior year.
  • Raw Materials reached $4.5 million in Q4 2018 per APYX's latest filing, down from $5.2 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.2 million in Q4 2017 to a low of $4.5 million in Q4 2016.
  • Average Raw Materials over 3 years is $4.7 million, with a median of $4.5 million recorded in 2016.
  • Peak YoY movement for Raw Materials: rose 14.2% in 2017, then fell 12.43% in 2018.
  • A 3-year view of Raw Materials shows it stood at $4.5 million in 2016, then increased by 14.2% to $5.2 million in 2017, then decreased by 12.43% to $4.5 million in 2018.
  • Per Business Quant, the three most recent readings for APYX's Raw Materials are $4.5 million (Q4 2018), $5.2 million (Q4 2017), and $4.5 million (Q4 2016).